Cooperating with NGN2 and SOX11, intravenous injection of overexpressing viruses has been shown to improve the reprogramming efficiency of human glioma cells into terminally-differentiated neuron-like cells, thus delaying tumor progression and significantly prolonging the survival of tumor-bearing mice [141]. The gene discussed is NEUROG2; the disease is neoplasm.